HomeRAPT • NASDAQ
add
Rapt Therapeutics Inc
Previous close
$0.89
Day range
$0.81 - $0.93
Year range
$0.79 - $9.64
Market cap
111.54M USD
Avg Volume
851.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 54.46M | 63.97% |
Net income | -53.25M | -72.46% |
Net profit margin | — | — |
Earnings per share | -1.22 | -50.62% |
EBITDA | -54.18M | -64.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 231.06M | 45.44% |
Total assets | 240.32M | 38.65% |
Total liabilities | 50.42M | 91.76% |
Total equity | 189.90M | — |
Shares outstanding | 132.01M | — |
Price to book | 0.62 | — |
Return on assets | -78.08% | — |
Return on capital | -92.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -53.25M | -72.46% |
Cash from operations | -10.44M | 62.39% |
Cash from investing | -843.00K | -104.08% |
Cash from financing | 143.12M | 31,147.82% |
Net change in cash | 131.84M | 2,080.40% |
Free cash flow | 9.44M | 156.49% |
About
Founded
2015
Headquarters
Website
Employees
68
